跳至主要内容
临床试验/IRCT2016111930962N1
IRCT2016111930962N1已完成3 期

Effects of Cumin (Cuminum cyminum) soft capsule on glycemic markers, lipid profile, and leptin in prediabetic patients.

Vice President of Research, Shahrekord University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 85 years(—)
性别
All

入选标准

  • FBS between 100-125mg/dl or 2 hours after GTT (75mg glucose) BS between 140-199 mgldl or HbA1C between 5.7-6.7; Patients without liver, renal, or endocrine disorders or malignancy; Patients who do not use any drugs with significant interaction with cumin like anti-depressant; Willing to participation and filling the written consent
  • Exclusion criteria: not willing to participation; disobedience from the study protocol; having special diets; any liver, renal, or endocrine disorders or malignancy during the intervention; consuming vitamin D, omega-3, selenium, or anti-depressant drugs; change in the drug history during the intervention
  • 7-using insulin

排除标准

  • 未提供

研究者

发起方
Vice President of Research, Shahrekord University of Medical Sciences

相似试验